On 30 MAY Harman International Industries Inc./DE/ (NYSE:HAR) reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.12. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was up 32.2% on a year-over-year basis. On average, analysts predict that Harman International Industries Inc./DE/ will post $4.37 earnings per share for the current fiscal year. Harman International Industries Inc./DE/ (NYSE:HAR) net profit margin is 3.90% and weekly performance is 2.84%. On last trading day company shares ended up $108.23. Analysts mean target price for the company is $119.00. Harman International Industries Inc./DE/ (NYSE:HAR) distance from 50-day simple moving average (SMA50) is 1.80%.
On 28 MAY Daktronics, Inc. (NASDAQ:DAKT) reported Q4 EPS of $0.04, $0.10 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $136.2 million versus the consensus estimate of $139 million. Daktronics, Inc. (NASDAQ:DAKT) shares advanced 0.25% in last trading session and ended the day on $11.88. DAKT Gross Margin is 25.20% and its return on assets is 6.60%. Daktronics, Inc. (NASDAQ:DAKT) quarterly performance is -14.04%.
Fabrinet (NYSE:FN) reported $0.34 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.33 by $0.01. The company had revenue of $167.70 million for the quarter, compared to the consensus estimate of $155.60 million. During the same quarter last year, the company posted $0.33 earnings per share. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. Fabrinet (NYSE:FN) shares moved up 0.78% in last trading session and was closed at $20.70, while trading in range of $20.23 – $20.84. Fabrinet (NYSE:FN) year to date (YTD) performance is 0.68%.
On 9 JUNE BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced that the U.S. Food and Drug Administration (:FDA) has approved Bunavail (buprenorphine and naloxone buccal film) for the maintenance therapy of opioid dependence. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) ended the last trading day at $11.41. Company weekly volatility is calculated as 8.73% and price to cash ratio as 6.27. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) showed a positive weekly performance of 20.23%.
United Utilities Group PLC (ADR) (OTCMKTS:UUGRY) on last trading day company shares ended up $29.86.